Program Director/Principal Investigator (Last, First, Middle): The overall goal of this Project is to identify cellular proteins that are required for Ebola virus replication. Ebola viruses pose significant risks to human health and national security. The 2014 outbreak in Western Africa infected more than 28,000 people and caused more than 11,000 deaths (per WHO statistics). Although vaccine candidates are showing promise in clinical trials, no clinically approved drugs are available and basic information about Ebola virus replication is lacking. Like all viruses, Ebola virus depends on cellular proteins for its replication. This dependence creates a potential ?Achilles heel? that may be exploited to develop new approaches to treat Ebola virus infections. By studying Ebola virus-host cell interactions, we gain insight into the mechanisms of action of viral proteins and the strategies that the virus uses to interface with its host. However, relatively few host factors of Ebola virus replication have been reported and no systematic, genome- wide analyses have been performed. To address this gap, we will apply complementary technologies to develop high quality maps of Ebola virus-host cell interactions.
In Aim 1 we perform a high content, genome- wide RNAi screen under BSL4 conditions with wildtype Ebola virus to identify novel host factors required for Ebola virus replication. The capacity to perform such a screen is unique to the research team. Since the host factors identified in the siRNA screen could act directly or indirectly to affect Ebola virus replication, in Aim 2 we propose to identify cellular proteins that bind to Ebola virus replication proteins. Complementary protein- protein interaction discovery technologies (yeast two-hybrid assay and co-affinity purification plus mass spectrometry) are used to develop a more comprehensive Ebola virus-host cell protein interaction network than could be achieved with any single approach. Since the sequences of Ebola virus strains differ between outbreaks and the impact of these genetic changes on host cell interactions is not known, we systematically compare host cell binding partners of a 2014 outbreak strain to those of Ebola Zaire (1976). Host cell factors from Aims 1 and 2 are integrated with existing large-scale data sets in Aim 3 to develop strain-specific Ebola virus-host cell protein interaction networks. To create a more complete understanding of regulatory effects of the virus-host interactions, we will enrich the network in indirect transcriptional interactions using high- throughput RNA-seq profiling of a subset of host factors selected from Aims 1 and 2. Our research team is well qualified to accomplish the goals of this Project, having expertise in high-throughput screening of BSL4 viruses, virus-host cell protein interactions, RNA-Seq profiling, and network-based bioinformatic analyses. Host factors will be tested for their effects on virus infection in Projects 1 and 3, and characterized by biophysical and structural methods in Core B and Project 2. Together these studies will develop the most comprehensive analysis of Ebola virus-host cell interactions to date. The data is integral to the mission of this Program and is expected to stimulate hypothesis-driven experiments in broader Ebola virus research community. 0925-0001/0002 (Rev. 08/12) Page Continuation Format Page

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI120943-01A1
Application #
9149561
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2016-07-07
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Knoverek, Catherine R; Amarasinghe, Gaya K; Bowman, Gregory R (2018) Advanced Methods for Accessing Protein Shape-Shifting Present New Therapeutic Opportunities. Trends Biochem Sci :
Johnson, Britney; VanBlargan, Laura A; Xu, Wei et al. (2018) Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability. Immunity 48:487-499.e5
Klein, Roger D; Shu, Qin; Cusumano, Zachary T et al. (2018) Structure-Function Analysis of the Curli Accessory Protein CsgE Defines Surfaces Essential for Coordinating Amyloid Fiber Formation. MBio 9:
Hung, Putzer J; Johnson, Britney; Chen, Bo-Ruei et al. (2018) MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining. Mol Cell 71:332-342.e8
Johnston, Adam B; Hilton, Denise M; McConnell, Patrick et al. (2018) A novel mode of capping protein-regulation by twinfilin. Elife 7:
Dashti, Hesam; Wedell, Jonathan R; Westler, William M et al. (2018) Applications of Parametrized NMR Spin Systems of Small Molecules. Anal Chem 90:10646-10649
Johnson, Britney; McConnell, Patrick; Kozlov, Alex G et al. (2018) Allosteric Coupling of CARMIL and V-1 Binding to Capping Protein Revealed by Hydrogen-Deuterium Exchange. Cell Rep 23:2795-2804
Holze, Cathleen; Michaudel, ChloƩ; Mackowiak, Claire et al. (2018) Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat Immunol 19:130-140
Warfield, Kelly L; Howell, Katie A; Vu, Hong et al. (2018) Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms. J Infect Dis 218:S553-S564
Su, Zhaoming; Wu, Chao; Shi, Liuqing et al. (2018) Electron Cryo-microscopy Structure of Ebola Virus Nucleoprotein Reveals a Mechanism for Nucleocapsid-like Assembly. Cell 172:966-978.e12

Showing the most recent 10 out of 17 publications